The estimated Net Worth of Sue Bailey is at least $3.16 Million dollars as of 4 March 2021. Sue Bailey owns over 8,168 units of Emergent Biosolutions Inc stock worth over $184,912 and over the last 17 years he sold EBS stock worth over $2,640,591. In addition, he makes $338,000 as Independent Director at Emergent Biosolutions Inc.
Sue has made over 10 trades of the Emergent Biosolutions Inc stock since 2015, according to the Form 4 filled with the SEC. Most recently he sold 8,168 units of EBS stock worth $754,478 on 4 March 2021.
The largest trade he's ever made was exercising 19,920 units of Emergent Biosolutions Inc stock on 12 May 2015 worth over $199,997. On average, Sue trades about 3,991 units every 79 days since 2007. As of 4 March 2021 he still owns at least 24,427 units of Emergent Biosolutions Inc stock.
You can see the complete history of Sue Bailey stock trades at the bottom of the page.
Dr. Sue Bailey, M.D., is an Independent Director of the Company. Dr. Bailey served as a news analyst for NBC Universal, a media and entertainment company, from November 2001 to August 2006. Previously, Dr. Bailey served as Administrator, National Highway Traffic Safety Administration, as Assistant Secretary of Defense (Health Affairs) and as Deputy Assistant Secretary of Defense (Clinical Services). Dr. Bailey is a former faculty member at Georgetown Medical School and U.S. Navy officer, having achieved the rank of Lt. Commander, U.S. Navy Reserve. Dr. Bailey received her D.O. from Philadelphia College of Osteopathic Medicine and a B.S. from the University of Maryland. Bailey's qualifications to serve on our Board of Directors include her medical background and prior senior positions in government.
As the Independent Director of Emergent Biosolutions Inc, the total compensation of Sue Bailey at Emergent Biosolutions Inc is $338,000. There are 17 executives at Emergent Biosolutions Inc getting paid more, with Robert Kramer having the highest compensation of $3,693,820.
Sue Bailey is 76, he's been the Independent Director of Emergent Biosolutions Inc since 2007. There are 2 older and 18 younger executives at Emergent Biosolutions Inc. The oldest executive at Emergent Biosolutions Inc is Louis Sullivan, 86, who is the Independent Director.
Sue's mailing address filed with the SEC is 400 PROFESSIONAL DR, SUITE 400, , GAITHERSBURG, MD, 20879.
Over the last 18 years, insiders at Emergent Biosolutions Inc have traded over $131,382,266 worth of Emergent Biosolutions Inc stock and bought 4,647 units worth $138,981 . The most active insiders traders include Seamus Mulligan, Fuad El Hibri und Shahzad Malik. On average, Emergent Biosolutions Inc executives and independent directors trade stock every 21 days with the average trade being worth of $147,206. The most recent stock trade was executed by Kathryn C Zoon on 4 June 2024, trading 10,000 units of EBS stock currently worth $61,100.
emergent biosolutions is a global life sciences company dedicated to one simple mission—to protect and enhance life. we develop, manufacture, and deliver a portfolio of medical countermeasures for biological and chemical threats as well as emerging infectious diseases. through our work, we envision protecting and enhancing 50 million lives with our products by 2025. additional information about the company may be found at www.emergentbiosolutions.com. follow us @emergentbiosolu and @life_at_emergent
Emergent Biosolutions Inc executives and other stock owners filed with the SEC include: